Top

European Archives of Psychiatry and Clinical Neuroscience

Published in:

01-12-2018 | Letter to the Editor

Postmortem studies indicate altered cell chemical composition of the suprachiasmatic nucleus in mood disorders

Authors: Hans-Gert Bernstein, Bernhard Bogerts, Gerburg Keilhoff, Johann Steiner

Published in: European Archives of Psychiatry and Clinical Neuroscience | Issue 8/2018

Excerpt

Dear Sir, …

Zaki NFW, Spence DW, BaHammam AS, Pandi-Perumal SR, Cardinali DP, Brown GM (2017) Chronobiological theories of mood disorder. Eur Arch Psychiatry Clin Neurosci. https://doi.org/10.1007/s00406-017-0835-5 (Online 2017 Sep 11) CrossRefPubMed

Hofman MA, Swaab DF (1992) The human hypothalamus: comparative morphometry and photoperiodic influences. Prog Brain Res 93:133–147CrossRef

Hofman MA, Swaab DF (1993) Diurnal and seasonal rhythms of neuronal activity in the suprachiasmatic nucleus of humans. J Biol Rhythms 8:283–295CrossRef

Bernstein HG, Heinemann A, Krell D, Dobrowolny H, Bielau H, Keilhoff G, Bogerts B (2005) Hypothalamic nitric oxide synthase in affective disorder: focus on the suprachiasmatic nucleus. Cell Mol Biol (Noisy-le-grand) 51:279–284

Zhou JN, Riemersma RF, Unmehopa UA, Hoogendijk WJ, van Heerikhuize JJ, Hofman MA, Swaab DF (2001) Alterations in arginine vasopressin neurons in the suprachiasmatic nucleus in depression. Arch Gen Psychiatry 58:655–662CrossRef

Bernstein HG, Heinemann A, Krell D, Mawrin C, Bielau H, Danos P, Diekmann S, Keilhoff G, Bogerts B, Baumann B (2002) Further immunohistochemical evidence for impaired NO signaling in the hypothalamus of depressed patients. Ann N Y Acad Sci 973:91–93CrossRef

Wu YH, Ursinus J, Zhou JN, Scheer FA, Ai-Min B, Jockers R, van Heerikhuize J, Swaab DF (2013) Alterations of melatonin receptors MT1 and MT2 in the hypothalamic suprachiasmatic nucleus during depression. J Affect Disord 148:357–367. https://doi.org/10.1016/j.jad.2012.12.025 CrossRefPubMed

Bernstein HG, Keilhoff G, Steiner J, Dobrowolny H, Bogerts B (2011) Nitric oxide and schizophrenia: present knowledge and emerging concepts of therapy. CNS Neurol Disord Drug Targets 10:792–807CrossRef

Gao SF, Qi XR, Zhao J, Balesar R, Bao AM, Swaab DF (2013) Decreased NOS1 expression in the anterior cingulate cortex in depression. Cereb Cortex 23:2956–2964. https://doi.org/10.1093/cercor/bhs285 CrossRefPubMed

10.

Kudlow P, Cha DS, Carvalho AF, McIntyre RS (2016) Nitric oxide and major depressive disorder: pathophysiology and treatment implications. Curr Mol Med 16:206–215CrossRef

11.

Vadnie CA, McClun CA (2017) Circadian rhythm disturbances in mood disorders: insights into the role of the suprachiasmatic nucleus. Neural Plast 2017:1504507. https://doi.org/10.1155/2017/1504507 CrossRefPubMedPubMedCentral

12.

Plano SA, Golombek DA, Chiesa JJ (2010) Circadian entrainment to light-dark cycles involves extracellular nitric oxide communication within the suprachiasmatic nuclei. Eur J Neurosci 31:876–882. https://doi.org/10.1111/j.1460-9568.2010.07120.x CrossRefPubMed

13.

Bernstein HG, Bogerts B, Keilhoff G (2005) The many faces of nitric oxide in schizophrenia. A review. Schizophr Res 78:69–86CrossRef

14.

Bernstein HG, Heinemann A, Steiner J, Bogerts B (2010) Schizophrenia, sleep disturbances and the suprachiasmatic nucleus: reduced nitric oxide synthase may matter. Med Hypotheses 74:397–398. https://doi.org/10.1016/j.mehy.2009.08.026 CrossRefPubMed

Title: Postmortem studies indicate altered cell chemical composition of the suprachiasmatic nucleus in mood disorders
Authors: Hans-Gert Bernstein
Bernhard Bogerts
Gerburg Keilhoff
Johann Steiner
Publication date: 01-12-2018
Publisher: Springer Berlin Heidelberg
Published in: European Archives of Psychiatry and Clinical Neuroscience / Issue 8/2018
Print ISSN: 0940-1334
Electronic ISSN: 1433-8491
DOI: https://doi.org/10.1007/s00406-017-0849-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Postmortem studies indicate altered cell chemical composition of the suprachiasmatic nucleus in mood disorders

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 8/2018

Obituary for Professor Hinderk Meiners Emrich, MD PhD

Cognitive Behavioral Analysis System of Psychotherapy as group psychotherapy for chronically depressed inpatients: a naturalistic multicenter feasibility trial

PsychotherapyPlus: augmentation of cognitive behavioral therapy (CBT) with prefrontal transcranial direct current stimulation (tDCS) in major depressive disorder—study design and methodology of a multicenter double-blind randomized placebo-controlled trial

Bipolar spectrum in major depressive disorders

Keap1–Nrf2 signaling pathway confers resilience versus susceptibility to inescapable electric stress

Influence of depressed patients’ expectations prior to electroconvulsive therapy on its effectiveness and tolerability (Exp-ECT): a prospective study